Therapeutics
Aditxt Inc. to Showcase Adimune's Innovations in Autoimmune Therapeutics During July 22 Livestream
Aditxt Inc. (NASDAQ: ADTX) will host a livestream to discuss Adimune Inc.'s advancements in autoimmune therapeutics, highlighting the subsidiary's innovative approach and the growing market opportunities.
Sino Biological Introduces ProPure™ Endotoxin-Free Proteins, Enhancing Research and Therapeutic Development
Sino Biological US, Inc. launches ProPure™, a line of ultra-pure, endotoxin-free recombinant proteins produced in the USA, setting a new industry standard for research and therapeutic applications.
Creative Biolabs Advances mRNA Therapeutics with Comprehensive Solutions
Creative Biolabs is enhancing the development of mRNA therapies, offering innovative solutions that address key challenges in stability, delivery, and scalability, pivotal for treatments ranging from HIV to cancer.
New Therapeutic Target Offers Hope in Preventing Cancer from Chronic Gut Inflammation
Research highlights a promising therapeutic target that could prevent cancer in patients suffering from chronic inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, offering new hope for young patients particularly affected by these conditions.
Creative Biolabs Advances Lactobacillus Research with Comprehensive Probiotic Development Services
Creative Biolabs launches advanced Lactobacillus development solutions, offering comprehensive screening, validation, and engineering services for probiotic research. The company's multi-dimensional approach aims to enhance understanding of microbiome interactions and potential therapeutic applications.